Oppenheimer starts IBM with Outperform

Not your father’s IBM, says Oppenheimer as it starts coverage with outperform
Oppenheimer initiated coverage of International Business Machines (NYSE:IBM) with an “Outperform” rating and a $320 price target, citing the company’s transformation into a software-driven business with strong growth potential.
Oppenheimer initiates IBM coverage with Outperform rating
IBM (IBM) stock are in focus after Oppenheimer analysts initiated coverage on the stock with an Outperform rating and a $320 price target. Julie Hyman and Josh Lipton take a closer look at the analyst commentary,
Oppenheimer starts IBM with Outperform amid pivot to software
Oppenheimer initiated coverage of IBM (IBM) with an Outperform rating and $320 price target The firm’s bullish stance is based on the view
Oppenheimer Initiates Coverage of International Business Machines (IBM) with Outperform Recommendation
Fintel reports that on February 11, 2025, Oppenheimer initiated coverage of International Business Machines (NYSE:IBM) with a Outperform recommendation. Analyst Price Forecast Suggests 12.51% Downside As of January 28,
IBM initiated at Outperform as software accelerates at Big Blue: Oppenheimer
IBM (NYSE:IBM) was initiated with an Outperform rating by Oppenheimer due in part to double-digit revenue growth in its software segment, driven by its Red Hat offerings. "Red Hat specifically has recently expanded its product focus with multiple partner integrations that can help drive a high-teens to 20% growth for the segment,
IBM initiated with an Outperform at Oppenheimer
Oppenheimer analyst Param Singh initiated coverage of IBM (IBM) with an Outperform rating and $320 price target Maximize Your Portfolio with
IBM Stock Has 28% Upside, Says Analyst. Now Could Be the Time to Buy.
Oppenheimer analyst Param Singh initiated coverage of IBM stock with an Outperform rating and a $320 price target.
'Not Your Father's IBM' - Analyst Says Company's Shift To A Software-Centric Company Is Overlooked
Oppenheimer analyst predicts IBM's Red Hat-driven software growth could lead to 20% growth, boosting margins and stock value.
ETF Daily News7d
Oppenheimer (NYSE:OPY) Downgraded by StockNews.com to Buy
Empowered Funds LLC grew its holdings in Oppenheimer by 4.9% during the 4th quarter. Empowered Funds LLC now owns 34,511 shares of the financial services provider’s stock worth $2,212,000 after ...
Yahoo Finance19d
Exelixis Stock Falls as Oppenheimer Downgrades Over Drug Differentiation Concerns
Exelixis (NASDAQ:EXEL) is down 5.95% to $32.10 as of 11:04 AM ET Friday, following a downgrade from Oppenheimer ... a more neutral outlook on the stock.